The role of Venous Thromboembolism (VTE) extends to the prevention of future episodes. Patients who have experienced VTE are at an increased risk of developing the condition again in the future. Therefore, clinicians may recommend long-term anticoagulation therapy to prevent recurrence. In some cases, surgical intervention may also be recommended to remove the clot or to insert a filter to prevent future clots from traveling to the lungs.
Venous Thromboembolism (VTE) is a serious medical condition that plays a crucial role in the diagnosis, treatment, and prevention of blood clots. By identifying patients who are at risk, clinicians can take appropriate measures to prevent the development of VTE and to diagnose and treat the condition promptly when it does occur.
In Australia, Venous Thromboembolism (VTE) is one of the main causes of death that may be avoided. Compared to bowel cancer, breast cancer, and auto accidents, it is the leading cause of mortality. Every year, over 14,000 Australians acquire a VTE. In around 5,000 of these situations, a fatality occurs1. The majority of VTEs may be avoided, and hospitalisation is significantly linked to their development. Assessing risk factors and offering the right prophylactic are the keys to effective prevention.
Read More- https://cmiblogdailydose.blogspot.com/2023/03/venous-thromboembolism-vte-is-referred.html
